Literature DB >> 1094483

A review of the cardiovascular effects and toxicity of tricyclic antidepressants.

J W Jefferson.   

Abstract

The tricyclic antidepressants have potent and complex effects on the cardiovascular system, both directly and through interactions with other drugs. Through a combination of anticholinergic activity, direct myocardial depressant activity and an effect on the adrenergic neuron, they can cause a combination of arrhythmias, blood pressure abnormalities and congestive heart failure. These changes, although most common with overdose, can occur at therapeutic levels. In addition a number of drug-drug interactions can occur between the tricyclics and agents used in the treatment of cardiovascular disease, as exemplified by tricyclic antagonism of the antihypertensive effect of guanethidine. Awareness of these factors is necessary to insure proper therapeutic utilization of the tricyclics as well as to treat effectively their toxicity.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1094483     DOI: 10.1097/00006842-197503000-00006

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  41 in total

1.  Cardiovascular effects of tricyclic and tetracyclic antidepressants.

Authors:  C Bilgi; R Campbell
Journal:  Can Fam Physician       Date:  1979-05       Impact factor: 3.275

2.  Treatment of haemodynamic and electrocardiographic side-effects resulting from imipramine toxicity in rats and dogs.

Authors:  V B Fiedler; B Kettenbach; H Göbel; R E Nitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-08       Impact factor: 3.000

Review 3.  Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-03       Impact factor: 9.546

4.  Toxicological evaluation of imipramine in combination with adriamycin and strophanthin.

Authors:  G Zbinden; J Elsner; H Bolliger
Journal:  Agents Actions       Date:  1977-09

5.  Cardiovascular effects of amitriptyline, mianserin, zimelidine and nomifensine in depressed patients.

Authors:  C D Burgess; S Montgomery; J Wadsworth; P Turner
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

Review 6.  Drug therapy for geriatric depression.

Authors:  R Bressler; M D Katz
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

Review 7.  Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-10       Impact factor: 9.546

8.  Activity of the uptake-1 norepinephrine transporter as measured by I-123 MIBG in heart failure patients with a loss-of-function polymorphism of the presynaptic alpha2C-adrenergic receptor.

Authors:  Myron C Gerson; Lynne E Wagoner; Nancy McGuire; Stephen B Liggett
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

9.  The effect of tricyclic antidepressant drugs on the heart.

Authors:  P Dumovic; G D Burrows; J Vohra; B Davies; B A Scoggins
Journal:  Arch Toxicol       Date:  1976-08-18       Impact factor: 5.153

10.  Electrophysiological effects of imipramine in nontreated and in imipramine-pretreated rat atrial fibres.

Authors:  J Manzanares; J Tamargo
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.